Where does Infectious Disease Research Institute rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Infectious Disease Research Institute ranks #14,688 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Infectious Disease Research Institute hold?

Infectious Disease Research Institute holds 20 US utility patents granted between 2015 and 2022, spanning 10 technology areas.

What is Infectious Disease Research Institute's Innovation Score?

Infectious Disease Research Institute has an Innovation Score of 33.6 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Infectious Disease Research Institute focus on?

Infectious Disease Research Institute's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 20 patents, ranking #1,122 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Infectious Disease Research Institute's patent grant rate increasing or decreasing?

Infectious Disease Research Institute's recent grant velocity is -18% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Infectious Disease Research Institute's patents?

Infectious Disease Research Institute's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Infectious Disease Research Institute patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Infectious Disease Research Institute

USPTO PatentsView assignee record - 20 granted patents across 10 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Infectious ranks #14,688 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 10 technology areas.

#14,688
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.6/100): 18.4
avg claims per patent: -18%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14688 · US Corporation #14,688 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,688/49,997
PHOTO-FINISH Imbria Pharmaceuticals
CPC-FOCUS A61K · 10 areas
INNOV-THIN 33.6/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -18% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Imbria Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Infectious’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (31%) Velocity 0.8 pts (2%) Breadth 11.2 pts (33%) Claim depth 11.0 pts (33%)

Qualcomm Incorporated · highest

85
Artery Technology · near

34
Crystaphase Products · near

34
Daiwa Kasei Kogyo · near

34
Infectious Disease… · this assignee

34
Pieris Pharmaceuticals · near

34
3D Lighting… · lowest

7

What this shows Infectious's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Infectious?

Each dot is one of Infectious’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Infectious’s own 18.4 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Infectious vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Infectious's grants concentrate

Infectious Disease Research Institute is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2015. By volume, Infectious sits between Imbria Pharmaceuticals, Inc. and Interman Corporation.

Infectious's three-year grant acceleration

Infectious Disease Research Institute shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Imbria Pharmaceut…

20
Imiracle (HK)

20
Inait

20
Incheon Universit…

20
Inflazome

20
Inpaq Technology

20
Interface Optoele…

20
Interman

20
Infectious Diseas… ◀

20

What this shows Infectious holds 20 patents at rank #14,680, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Infectious

By rank, the assignees closest to #14,680 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Infectious's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Infectious, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Infectious ranks #1,122 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Crystaphase Products, Inc. 34 Pieris Pharmaceuticals GmbH 34 Artery Technology Company 34 Daiwa Kasei Kogyo Kabushiki Kaisha 34

Infectious's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Infectious Disease Research Institute patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2016	4	20.0%
2017	2	10.0%
2018	4	20.0%
2020	3	15.0%
2021	5	25.0%
2022	1	5.0%

Which technologies does Infectious Disease Research Institute patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

Y02A - Technologies FOR Adaptation TO Climate Change 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

C12Y - Enzymes 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Infectious Disease Research Institute's patent record in context - here's where to go next.

Infectious Disease Research Institute's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #14,688 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Infectious Disease Research Institute against Imbria Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.